Utah Medical Products, Inc. (NASDAQ:UTMD) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Wednesday.

Separately, ValuEngine upgraded Utah Medical Products from a “sell” rating to a “hold” rating in a research note on Tuesday, June 6th.

Shares of Utah Medical Products (NASDAQ:UTMD) traded down 0.170% during mid-day trading on Wednesday, reaching $73.225. The company had a trading volume of 2,052 shares. Utah Medical Products has a 52 week low of $56.30 and a 52 week high of $75.00. The company has a market capitalization of $272.18 million, a price-to-earnings ratio of 20.999 and a beta of 0.74. The stock has a 50 day moving average of $71.31 and a 200-day moving average of $65.23.

ILLEGAL ACTIVITY WARNING: “Utah Medical Products, Inc. (UTMD) Stock Rating Upgraded by BidaskClub” was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/09/utah-medical-products-inc-utmd-stock-rating-upgraded-by-bidaskclub.html.

A number of institutional investors have recently modified their holdings of UTMD. Prudential Financial Inc. acquired a new position in shares of Utah Medical Products during the second quarter worth about $233,000. WCM Investment Management CA increased its position in shares of Utah Medical Products by 0.9% in the second quarter. WCM Investment Management CA now owns 81,912 shares of the medical instruments supplier’s stock worth $5,930,000 after buying an additional 695 shares in the last quarter. Everett Harris & Co. CA acquired a new position in shares of Utah Medical Products during the second quarter worth about $210,000. Rice Hall James & Associates LLC increased its position in shares of Utah Medical Products by 1.1% in the second quarter. Rice Hall James & Associates LLC now owns 3,829 shares of the medical instruments supplier’s stock worth $277,000 after buying an additional 40 shares in the last quarter. Finally, Bessemer Group Inc. increased its position in shares of Utah Medical Products by 39.4% in the second quarter. Bessemer Group Inc. now owns 4,600 shares of the medical instruments supplier’s stock worth $333,000 after buying an additional 1,300 shares in the last quarter. Institutional investors own 65.51% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Receive News & Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related companies with MarketBeat.com's FREE daily email newsletter.